Vineet Laboratories Limited (BOM:543298)
India · Delayed Price · Currency is INR 31.10
+0.45 (1.47%)
At close: Feb 13, 2026
Vineet Laboratories Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Revenue | 570.37 | 749.95 | 1,506 | 2,123 | 1,912 | 2,435 |
Other Revenue | 14.12 | 19.58 | 3.73 | - | - | - |
Revenue | 584.49 | 769.53 | 1,510 | 2,123 | 1,912 | 2,435 |
Revenue Growth (YoY) | -48.47% | -49.03% | -28.89% | 11.05% | -21.48% | - |
Cost of Revenue | 571.05 | 730.76 | 1,181 | 1,761 | 1,497 | 2,000 |
Gross Profit | 13.44 | 38.77 | 329.08 | 361.93 | 414.24 | 434.54 |
Selling, General & Admin | 44.59 | 53.75 | 64.83 | 60.71 | 58.31 | 56.38 |
Other Operating Expenses | 71.61 | 128.27 | 188.52 | 227.99 | 224.31 | 296.59 |
Operating Expenses | 141.47 | 207.04 | 278.54 | 312.43 | 302.78 | 371.04 |
Operating Income | -128.03 | -168.27 | 50.54 | 49.5 | 111.46 | 63.5 |
Interest Expense | -45.04 | -38.31 | -38.49 | -26.58 | -14.89 | -26.67 |
Interest & Investment Income | - | - | 0.35 | 1.23 | 1.62 | 0.46 |
Currency Exchange Gain (Loss) | 0.04 | 0.04 | 0.07 | 3.37 | 0.92 | 2.74 |
Other Non Operating Income (Expenses) | -1.47 | -1.47 | -9.32 | -7.22 | -5.65 | 0.54 |
EBT Excluding Unusual Items | -174.5 | -208 | 3.15 | 20.3 | 93.46 | 40.58 |
Gain (Loss) on Sale of Investments | 0.25 | 0.25 | 0.48 | - | - | - |
Pretax Income | -174.25 | -207.76 | 3.63 | 20.3 | 93.46 | 40.58 |
Income Tax Expense | -7.28 | -5.85 | -6.64 | 7.77 | 27.07 | 22.78 |
Net Income | -166.97 | -201.91 | 10.27 | 12.53 | 66.39 | 17.8 |
Net Income to Common | -166.97 | -201.91 | 10.27 | 12.53 | 66.39 | 17.8 |
Net Income Growth | - | - | -18.00% | -81.13% | 272.89% | - |
Shares Outstanding (Basic) | 9 | 9 | 9 | 9 | 9 | 9 |
Shares Outstanding (Diluted) | 9 | 9 | 9 | 9 | 9 | 9 |
Shares Change (YoY) | 0.27% | - | - | - | - | 2148.54% |
EPS (Basic) | -18.04 | -21.90 | 1.11 | 1.36 | 7.20 | 1.93 |
EPS (Diluted) | -18.04 | -21.90 | 1.11 | 1.36 | 7.20 | 1.93 |
EPS Growth | - | - | -18.30% | -81.13% | 272.84% | - |
Free Cash Flow | 53.7 | 104.46 | -94 | -172.5 | 76.32 | 274.86 |
Free Cash Flow Per Share | 5.80 | 11.33 | -10.20 | -18.71 | 8.28 | 29.81 |
Dividend Per Share | - | - | - | - | 1.000 | - |
Gross Margin | 2.30% | 5.04% | 21.80% | 17.05% | 21.67% | 17.85% |
Operating Margin | -21.91% | -21.87% | 3.35% | 2.33% | 5.83% | 2.61% |
Profit Margin | -28.57% | -26.24% | 0.68% | 0.59% | 3.47% | 0.73% |
Free Cash Flow Margin | 9.19% | 13.57% | -6.23% | -8.13% | 3.99% | 11.29% |
EBITDA | -102.76 | -143.25 | 75.73 | 73.23 | 131.62 | 81.57 |
EBITDA Margin | -17.58% | -18.62% | 5.02% | 3.45% | 6.88% | 3.35% |
D&A For EBITDA | 25.27 | 25.02 | 25.19 | 23.73 | 20.16 | 18.07 |
EBIT | -128.03 | -168.27 | 50.54 | 49.5 | 111.46 | 63.5 |
EBIT Margin | -21.91% | -21.87% | 3.35% | 2.33% | 5.83% | 2.61% |
Effective Tax Rate | - | - | - | 38.30% | 28.97% | 56.13% |
Revenue as Reported | 584.78 | 769.82 | 1,511 | 2,124 | 1,915 | 2,439 |
Advertising Expenses | - | 0.05 | 0.59 | 0.5 | 0.75 | 0.33 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.